Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was introduced more than 80 years ago, and it has changed medical strategies with respect to cancer. Many radioactive radionuclides have been developed, and functional, molecularly modified radiolabelled peptides have be...
Main Authors: | Kushal Chakraborty, Jagannath Mondal, Jeong Man An, Jooho Park, Yong-Kyu Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/971 |
Similar Items
-
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview
by: Andrea Cimini, et al.
Published: (2021-08-01) -
Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
by: Miriam Conte, et al.
Published: (2023-03-01) -
Theragnostic Radionuclide Pairs for Prostate Cancer Management: <sup>64</sup>Cu/<sup>67</sup>Cu, Can Be a Budding Hot Duo
by: Anupriya Chhabra, et al.
Published: (2022-11-01) -
Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989
by: Othman Al Musaimi
Published: (2024-03-01) -
Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review
by: Stefan Prado-Wohlwend, et al.
Published: (2022-10-01)